A Randomized, Double-Blind, Crossover, Phase IIa Study Comparing a Single-Application TPM/Oxycodone Patch versus Vehicle Patch in the Topical Treatment of Patients with Postherpetic Neuralgia

Trial Profile

A Randomized, Double-Blind, Crossover, Phase IIa Study Comparing a Single-Application TPM/Oxycodone Patch versus Vehicle Patch in the Topical Treatment of Patients with Postherpetic Neuralgia

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Postherpetic neuralgia
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Phosphagenics
  • Most Recent Events

    • 08 Jun 2016 Last checked against Australian New Zealand Clinical Trials Registry record.
    • 17 May 2016 Status changed from recruiting to completed, as reported in a Phosphagenics media release.
    • 29 Jan 2016 Primary endpoint (Change from baseline of average pain intensity scores assessed using NPRS between Treatment Period 1 and Treatment Period 2 at 24 hours and 72 hours) has not been met, as per Phosphagenics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top